Stay updated on Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page’s displayed revision/version was updated from v3.5.2 to v3.5.3, reflecting a maintenance or release change rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T22:21:06.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:01:49.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision label changed from v3.4.3 to v3.5.0. The change does not affect study information or page functionality.
    Difference
    0.1%
    Check dated 2026-03-19T23:44:09.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T20:40:56.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2; the rest of the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:39.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:30:37.000Z thumbnail image

Stay in the know with updates to Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.